QGEN - キアゲン (Qiagen N.V.)

QGENのニュース

   QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments  2021/07/07 20:05:00 Business Wire
GERMANTOWN, Md., & HILDEN, Germany--(BUSINESS WIRE)---- $QGEN #lifescience--QIAGEN launches the Workflow Configurator to help life science researchers simplify and optimize their laboratory experiments
   Aktie von Qiagen legt um 0,40 Prozent zu  2021/07/07 12:32:00 FinanzNachrichten
Die Qiagen-Aktie notiert am Mittwoch etwas fester. Das Papier kostete zuletzt 42,57 Euro. Ein Kursgewinn in Höhe von 17 Cent erfreut derzeit die Aktionäre von Qiagen. Zur Stunde wird die Aktie am A
   White & Case Advises QIA on Participation in Age of Learnings US$300 Million Financing Round | White & Case LLP  2021/07/06 09:56:43 CompanyNewsHQ
Global law firm White & Case LLP has advised Qatar Investment Authority (QIA), the sovereign wealth fund of the State View post on CompanyNewsHQ : White & Case Advises QIA on Participation in Age of Learnings US$300 Million Financing Round | White & Case LLP
   Verhaltene Kauflaune bei Aktie von Qiagen  2021/07/05 09:56:00 FinanzNachrichten
Der Kurs der dem Anteilsschein von Qiagen kommt kaum von der Stelle. Zuletzt zahlten Investoren für die Aktie 41,34 Euro. Die Wertschätzung der Börsenteilnehmer für die Qiagen-Aktie hat sich heute
   DGAP-DD: QIAGEN N.V. (english)  2021/07/02 20:10:00 FinanzNachrichten
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 02.07.2021 / 22:04 The issuer is solely responsible f
   Global $1.05 Billion Clinical Oncology Next Generation Sequencing Markets, 2015-2020, 2020-2025F, 2030F  2021/05/10 17:15:00 Benzinga
DUBLIN , May 10, 2021 /PRNewswire/ -- The "Clinical Oncology Next Generation Sequencing Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global clinical oncology next generation sequencing market is expected to grow from $0.44 billion in 2020 to $0.56 billion in 2021 at a compound annual growth rate (CAGR) of 27.3%. Major players in the clinical oncology next generation sequencing market are Thermo Fisher Scientific (Qiagen), Oxford Nanopore Technologies, QIAGEN, Myriad Genetics, Illumina, F. Hoffmann-La Roche, Perkin Elmer, Agilent Technologies, Pacific Bioscience, and Caris Life Sciences. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges.
   Qiagen Q1 Earnings Tops Estimates As Growth In Non-COVID-19 Products Boost Revenues  2021/05/04 11:10:37 Benzinga
Qiagen NV (NYSE: QGEN ) on Monday after-hours reported first-quarter revenue growth of 52% Y/Y to $567.2 million, exceeding prior guidance and beating analyst consensus by $9.68 million. Adjusted EPS $0.65 beat analyst consensus of $0.63 and exceeded prior company guidance of $0.60 - $0.62. Q1 revenues grew 48% Y/Y at constant exchange rates, faster than previously guided for at least 45%. By product category, consumables and related revenues … Full story available on Benzinga.com
   What Does Qiagen's Debt Look Like?  2021/04/12 07:49:00 Benzinga
Over the past three months, shares of Qiagen (NYSE:QGEN) decreased by 3.68%. Before having a look at the importance of debt, let us look at how much …
   One Step RT-PCR Kits Market With Top Players like Thermo Fisher Scientific, New England Biolabs, Boster Biological Technology Ltd, QIAGEN, Takara Bio (Takara Holdings), Jena Bioscience, Meridien Bioscience, Merck KGaA, Intact Genomics, PerkinElmer  2021/03/22 08:24:10 OpenPR
One-step RT-PCR kit is usually used to process multiple samples at a time that hits one or a few targets per time. Some of the examples of procedures that are conducted through one-step RT-PCR kits include high-throughput gene expression screening,
   Peer Schatz baut mit Resolve Biosciences sein zweites Qiagen  2021/03/18 11:00:00 manager magazin
Er baute Qiagen zum deutschen Biotechstar auf, dann musste Peer Schatz gehen. Im Interview spricht er erstmals über sein Aus und die ambitionierten Pläne für ein Comeback.
   What Does Qiagen's Debt Look Like?  2021/04/12 07:49:00 Benzinga
Over the past three months, shares of Qiagen (NYSE:QGEN) decreased by 3.68%. Before having a look at the importance of debt, let us look at how much …
   One Step RT-PCR Kits Market With Top Players like Thermo Fisher Scientific, New England Biolabs, Boster Biological Technology Ltd, QIAGEN, Takara Bio (Takara Holdings), Jena Bioscience, Meridien Bioscience, Merck KGaA, Intact Genomics, PerkinElmer  2021/03/22 08:24:10 OpenPR
One-step RT-PCR kit is usually used to process multiple samples at a time that hits one or a few targets per time. Some of the examples of procedures that are conducted through one-step RT-PCR kits include high-throughput gene expression screening,
   Peer Schatz baut mit Resolve Biosciences sein zweites Qiagen  2021/03/18 11:00:00 manager magazin
Er baute Qiagen zum deutschen Biotechstar auf, dann musste Peer Schatz gehen. Im Interview spricht er erstmals über sein Aus und die ambitionierten Pläne für ein Comeback.
   Cell Lysis and Disruption Market With Leading Players like Thermo Fisher Scientific, Merck KGaA, F. Hoffmann-La Roche Ltd, Qiagen NV, BD, Danaher, Bio-Rad Laboratories, Miltenyi Biotec GmbH, Claremont BioSolutions, LLC. Microfluidics International Corpora  2021/03/18 07:45:03 OpenPR
An off-the-shelf report on Cell Lysis and Disruption Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market
   Yourgene Health PLC - Appointment of VP of Sales North America - Vox Markets  2021/03/17 07:00:00 VOX Markets
Strategic hire to expand Yourgene's commercial footprint in North America. Scott brings over 25 years of industry experience, having held senior executive roles at large multinationals, most recently as Director of Sales for Clinical Genomics for QIAGEN in the US and Canada, where he led a commercial team selling into the Next Generation Sequencing, PCR and…

calendar